Orion Group Affiliation and Financial Status Disclosure: Routine Filing with No Material Impact on Shareholder Value


  • LigaChem has been a member of the Orion group since March 29, 2024, and this filing is a routine annual disclosure of its group affiliation status
  • Individual financials: total assets 660.7B KRW, total liabilities 83.3B KRW, total equity 577.5B KRW, debt ratio 14.42% indicating stable financial structure, but operating loss of 83.2B KRW and net loss of 63.5B KRW
  • Major shareholder PAN ORION Corp. Limited holds 25.29%, CEO Kim Yong-joo holds 3.31%, treasury shares 0.46%, other shareholders 70.45%
  • No material transactions such as inter-company loans, guarantees, or collateral provisions among affiliates
  • [AI Summary]This disclosure is a routine filing confirming LigaChem's status as an Orion group affiliate, reporting its financial condition and ownership structure. Despite ongoing operating losses, the company maintains a low debt ratio and stable capital base. However, no events directly affecting stock price such as new capital raising, dividends, or share buybacks are included, resulting in a neutral impact on shareholder value.

KOSDAQ Filing Information


  • Filing: Large Enterprise Group Status Disclosure [Annual And First Quarter Use (Individual Company)]
  • Company: LigaChem Biosciences (141080)
  • Submission: LigaChem Biosciences Inc.
  • Receipt: 06-01-2026
  • Under Fair Trade Commission (KFTC)